Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors

Title
Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors
Authors
Keywords
-
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 63, Issue 1, Pages 181-188
Publisher
Springer Nature
Online
2008-03-31
DOI
10.1007/s00280-008-0733-7

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now